参考文献

[1] Casadevall A, Fang F C. Revolutionary science[J]. mBio, 2016, 7(2）: e00158.

[2] Herbert S. The darwinian revolution revisited[J]. J Hist Biol, 2005, 38(1）: 51-66.

[3] Strasser B J. Who cares about the double helix?[J]. Nature, 2003, 422(6934）: 803-804.

[4] Lohff B. Serum therapy-Emil von Behring and the beginnings of research in immunity[J]. Dtsch Med Wochenschr, 1999, 124(44）: 1321-1322.

[5] Stanley W M. Crystalline tobacco-mosaic virus protein[J].  Am J Botany, 1937, 24(2）: 59-68.

[6] Casadevall A, Fang F C. Important science-It's all about the SPIN[J]. Infect Immun, 2009, 77(10）: 4177-4180.

[7] Preston B D, Poiesz B J, Loeb L A. Fidelity of HIV-1 reverse transcriptase[J]. Science, 1988, 242(4882）: 1168-1171.

[8] Casadevall A, Fang F C. Is the Nobel Prize good for science?[J]. Faseb J, 2013, 27(12）: 4682-4690.

[9] Ran F A, Hsu P D, Wright J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Prot, 2013, 8(11）:

2281-2308.

[10] Alkan S, Lehman C, Sarago C, et al. Polymerase chain reaction detection of immunoglobulin gene rearrangement and bcl-2 translocation in archival glass slides of cytologic material[J]. Diagn Mol Pathol, 1995, 4(1）: 25-31.

[11] Lane N. The unseen world: reflections on Leeuwenhoek (1677） ‘Concerning little animals'[J]. Philos Trans R Soc Lond B Biol Sci, 2015, 370(1666）: 20140344.

[12] Schierbeek A. The life and works of Antoni van Leeuwenhoek[M]. New York: Abelard-Schuman, 1959: 223.

[13] Anderson D. Still going strong: Leeuwenhoek at eighty[J]. Antonie Van Leeuwenhoek Int J Gen Mol Microbiol, 2014,

106(1）: 3-26.

[14] Gest H. The discovery of microorganisms by Robert Hooke and Antoni Van Leeuwenhoek, fellows of the Royal Society[J]. Notes Records Royal Soc Lond, 2004, 58(2）: 187-201.

[15] 钱秀萍, 陈代杰. 细菌简史与人类的永恒博弈[M]. 北京: 化学工业出版社, 2015: 32

[16] Markov S. Spallanzani Disproves the Theory of Spontaneous Generation[M]. Hackensack, NJ, USA: EBSCO, 2012: 821.

[17] Capanna E. Lazzaro Spallanzani: At the roots of modern biology[J]. J Exp Zool, 1999, 285(3）: 178-196.

[18] Schwartz M. The life and works of Louis Pasteur[J]. J Appl Microbiol, 2001, 91(4）: 597-601.

[19] Berche P. Louis Pasteur, from crystals of life to vaccination[J]. Clin Microbiol Infect, 2012, 18(Suppl 5）: 1-6.

[20] Berche B, Henkel M, Kenna R. Critical phenomena: 150 years since Cagniard de la Tour[J]. Revista Brasileira De Ensino De Fisica, 2009, 31(2）.

[21] Thomas T. Theodor Schwann: A founding father of biology and medicine[J]. Curr Med Iss, 2017, 15(4）: 299-301.

[22] Aszmann O C. The life and work of Theodore Schwann[J]. J Reconstr Microsurg, 2000, 16(4）: 291-295.

[23] Roll-Hansen N. Revisiting the Pouchet-Pasteur controversy over spontaneous generation: understanding experimental method[J]. Hist Philos Life Sci, 2018, 40(4）: 68.

[24] Raichvarg D. Louis Pasteur. L'empire des microbes[M]. France: Gallimard, 2000.

[25] Gross C G. Claude Bernard and the constancy of the internal environment[J]. Neuroscientist, 1998, 4(5）: 380-385.

[26] Walusinski O, Boller F, Henderson V W. Shining a Light on Some of the Most Famous 19th and 20th Century's Neuropsychologists[J]. Front Neurol Neurosci, 2019, 44: 192-229.

[27] Brock T D. (1988）: Robert Koch. A Life in Medicine and Bacteriology: In: Scientifific Revolutionaries: A Biographical Series. Science Tech. Publishers, Madison WI and J. Springer, Berlin, 364 pp., hard cover, 48-DM[J]. Eur J Protistol, 1989, 25(1）: 85.

[28] Blevins S M, Bronze M S. Robert Koch and the 'golden age'

of bacteriology[J]. Int J Infect Dis, 2010, 14(9）: e744-51.

[29] Cambau E, Drancourt M. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882[J]. Clin Microbiol Infect, 2014, 20(3）: 196-201.

[30] Gradmann C. Robert Koch and the white death: from tuberculosis to tuberculin[J]. Microbes Infect, 2006, 8(1）: 294-301.

[31] Di Serio F, Ambros S, Sano T, et al. Viroid diseases in pome and stone fruit trees and Koch's Postulates: A critical assessment[J]. Viruses, 2018, 10(11）: 612.

[32] Byrd A L, Segre J A. Infectious disease. Adapting Koch's postulates[J]. Science, 2016, 351(6270）: 224-226.

[33] Sah R, Neupane S. Diphtheria[J]. N Engl J Med, 2019, 381(13）: 1267.

[34] Haas L F. Pierre Fidele Bretonneau 1778—1862[J]. J J Neurol Neurosurg Psychiatry, 1994, 57(4）: 403.

[35] Nezelof C. Pierre Fidele Bretonneau 1778—1862. A pioneer in understanding infectious diseases[J]. Ann Diagn Pathol,

2002, 6(1）: 74-82.

[36] Ellis H. Edwin Klebs: discoverer of the bacillus of diphtheria[J]. Br J Hosp Med (Lond）, 2013, 74(11）: 641.

[37] Codell Carter K. Edwin Klebs' criteria for disease causality[J]. Medizinhist J, 1987, 22(1）: 80-89.

[38] Winau F, Winau R. Emil von Behring and serum therapy[J]. Microbes Infect, 2002, 4(2）: 185-188.

[39] Kaufmann S H. Remembering Emil von Behring: from Tetanus Treatment to Antibody Cooperation with Phagocytes[J]. mBio, 2017, 8(1）: e00117-17.

[40] Raju T N. Emil Adolf von Behring and serum therapy for diphtheria[J]. Acta Paediatr, 2006, 95(3）: 258-259.

[41] Haas L. Edmond Isidore Etienne Nocard (1850—1903）[J]. J Neurol Neurosurg Psychiatry, 2000, 69(1）: 130.

[42] Andrews M J. Medical history as portrayed on postage stamps[J]. J Natl Med Assoc, 1956, 48(1）: 1-9.

[43] Pucca M B, Cerni F A, Janke R, et al. History of envenoming therapy and current perspectives[J]. Front Immunol, 2019, 10: 1598.

[44] Rainey G J, Young J A. Antitoxins: novel strategies to target agents of bioterrorism[J]. Nat Rev Microbiol, 2004, 2(9）: 721-726.

[45] Waksman S A, Reilly H C, Schatz A. Strain specificity and production of antibiotic substances: V. Strain resistance of bacteria to antibiotic substances, especially to streptomycin[J]. Proc Natl Acad Sci U S A, 1945, 31(6）: 157-164.

[46] Ottenhoff T H. Overcoming the global crisis: “yes, we can”, but also for TB ... ?[J]. Eur J Immunol, 2009, 39(8）: 2014-2020.

[47] Mcshane H. Tuberculosis vaccines: beyond bacille Calmette-Guerin[J]. Philos Trans R Soc Lond B Biol Sci, 2011, 366(1579）: 2782-2789.

[48] Calmette A. Preventive Vaccination Against Tuberculosis with BCG[J]. Proc R Soc Med, 1931, 24(11）: 1481-1490.

[49] Greenwood M. Professor Calmette's statistical study of B.C.G. vaccination[J]. Br Med J, 1928, 1(3514）: 793-795.

[50] Glaziou P, Floyd K, Raviglione M C. Global epidemiology of tuberculosis[J]. Semin Respir Crit Care Med, 2018, 39(3）:

271-285.

[51] Kernodle D S. Decrease in the effectiveness of Bacille Calmette-Guerin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation[J]. Clin Infect Dis, 2010, 51(2）: 177-184.

[52] Lipworth S, Hammond R J, Baron V O, et al. Defining dormancy in mycobacterial disease[J]. Tuberculosis (Edinb）, 2016, 99: 131-142.

[53] Mandal S, Njikan S, Kumar A, et al. The relevance of persisters in tuberculosis drug discovery[J]. Microbiology, 2019, 165(5）: 492-499.

[54] Silverstein A M. Paul Ehrlich: Scientist for life: by Ernst Bäumler (English translation by Grant Edwards）, Holmes & Meier, 1984. $39.50 (xvi + 288 pages） ISBN 0 8419 0837 0[J]. Immunol Today, 1985, 6(10）: 311-312.

[55] 周程. 19世纪前后西方微生物学的发展——纪念恩格斯《自然辩证法》发表90周年[J]. 科学与管理, 2015, 35(6）: 3-9.

[56] Winau F, Westphal O, Winau R. Paul Ehrlich--in search of  the magic bullet[J]. Microbes Infect, 2004, 6(8）: 786-789.

[57] Bosch F, Rosich L. The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize[J]. Pharmacology, 2008, 82(3）: 171-179.

[58] Stern F. Paul Ehrlich: the founder of chemotherapy[J]. Angew Chem Int Ed Engl, 2004, 43(33）: 4254-4261.

[59] Kaufmann S H. Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff[J]. Nat Immunol, 2008, 9(7）: 705-712.

[60] Oesper R E. Gerhard Domagk and chemotherapy[J]. J Chem Edu, 1954, 31(4）: 188.

[61] Colebrook L. Gerhard Domagk, 1895—1964[J]. Biograph Mem Fell Royal Soc, 1964, 10: 39-50.

[62] Domagk G. Nobel Lecture[EB/OL]. NobelPrize.org.Nobel Media AB 2020. Sun. 5 Apr 2020. https:// www.nobelprize. org/prizes/medicine/1939/domagk/lecture/.

[63] 王渝生. 量子力学建立, 家用电器问世——世界科技一百年(四）, 20世纪20年代[J]. 科学中国人, 2011, (8）: 30-37.

[64] Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae[J]. Br J Exp Pathol, 1929, 10(3）: 226-236.

[65] Chain E, Florey H W, Gardner A D, et al. Penicillin as a chemotherapeutic agent[J]. Lancet, 1940, 236(6104）: 226-228.

[66] Riley H D, Jr. The story of penicillin (Alexander Fleming）[J]. J Okla State Med Assoc, 1972, 65(3）: 107-119.

[67] Fleming A. In-vitro tests of penicillin potency[J]. Lancet, 1942, 239(6199）: 732-733.

[68] Hare R. The scientifific activities of Alexander Fleming, other than the discovery of penicillin[J]. Med Hist, 1983, 27(4）:

347-372.

[69] Schatz A, Bugie E, Waksman S A. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria[J]. Proc Soc Exp Biol Med, 1944, 55(1）: 66-69.

[70] Waksman S A, Schatz A. Streptomycin–Origin, Nature, and Properties[J]. J Pharm Sci, 1945, 34(11）: 273-291.

[71] Reynolds D M, Schatz A, Waksman S A. Grisein, a new antibiotic produced by a strain of Streptomyces griseus[J]. Proc Soc Exp Biol Med, 1947, 64(1）: 50-54.

[72] Reilly H C, Schatz A, Waksman S A. Antifungal properties of antibiotic substances[J]. J Bacteriol, 1945, 49(6）: 585-594.

[73] Waksman S A, Schatz A. Strain specifificity and production of antibiotic substances[J]. Proc Natl Acad Sci U S A, 1943,

29(2）: 74-79.

[74] Schatz A, Waksman S A. Strain specifificity and production of antibiotic substances: IV. Variations among Actionomycetes, with special reference to Actinomyces griseus[J]. Proc Natl Acad Sci U S A, 1945, 31(5）: 129-137.

[75] Waksman S A, Schatz A. Strain specifificity and production of antibiotic substances: VI. Strain variation and production of streptothricin by Actinomyces lavendulae[J]. Proc Natl Acad Sci U S A, 1945, 31(7）: 208-214.

[76] Jones D, Schatz A. Methods of study of antiphage agents produced by microorganisms[J]. J Bacteriol, 1946, 52(3）: 327-335.

[77] Jones D, Metzger H J, Schatz A, et al. Control of Gram-negative bacteria in experimental animals by streptomycin[J]. Science, 1944, 100(2588）: 103-105.